查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1501289

北美四肢瘫痪护理设备市场－行业分析、规模、占有率、成长、趋势、预测（2031）- 依产品、依适应症、依最终用户、依国家/地区

North America Quadriplegia Care Devices Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America)
出版日期: | 出版商: Fairfield Market Research | 英文 166 Pages | 商品交期: 2-5个工作天内

价格
简介目录

由于脊髓损伤盛行率不断上升以及技术不断进步，北美四肢瘫痪护理设备的市场规模预计将大幅成长。该市场估计到2024年将达到5.0686亿美元，到2031年将成长到7.41亿美元，并以5.6%的稳定年复合成长率（CAGR）扩张。该成长是由对医院病床和专门医疗设备的强劲需求推动的，这些设备目的是改善四肢瘫痪患者的活动能力、舒适度和整体生活品质。

市场动态支持市场成长轨迹的是北美每年报告的脊髓损伤病例数量不断增加。根据国家脊髓损伤统计中心的资料，每年都会记录数千例新的脊髓损伤病例，需要先进的医疗解决方案，例如机械手臂系统、义肢和其他辅助装置。这些创新满足了四肢瘫痪患者的独特需求，并促进了更具包容性和协作性的医疗环境。

销售分析与市场展望 过去五年，北美四肢瘫痪护理设备市场稳步扩张，反映出对专业护理的需求不断成长。2016年至2020年的销售分析强调，在脊髓损伤盛行率上升和医疗技术进步等因素的推动下，这些设备的使用量持续增加。预计市场将继续呈上升趋势，重点是提供改善患者治疗效果的尖端解决方案。

本报告调查了北美四肢瘫痪护理设备市场，并依产品、适应症、最终用户、国家/地区以及进入该市场的公司的竞争趋势提供了市场概述。

目录

第1章 执行摘要

第2章 市场概述

  • 市场定义与细分
  • 市场动态
  • 用于支援和护理的新技术
  • 监管场景
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎（COVID-19）影响分析
  • 经济概况
  • PESTLE分析

第3章 价格分析，2018-2024

第4章 北美四肢瘫痪护理设备市场前景，2018-2031

  • 北美四肢瘫痪护理设备市场前景，依产品，价值（十亿美元），数量（台），2018-2031年
  • 北美四肢瘫痪护理设备市场前景，依适应症分类，价值（十亿美元），2018-2031年
  • 北美四肢瘫痪护理设备市场前景，依最终用户，价值（十亿美元），2018-2031年
  • 北美四肢瘫痪护理设备市场前景，依国家，价值（十亿美元），数量（台），2018-2031年

第5章 美国四肢瘫痪护理设备市场前景，2018-2031

第6章 加拿大四肢瘫痪护理设备市场前景，2018-2031

第7章 竞争态势

  • 2024年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • ReWalk Robotics
    • Ekso Bionics
    • Indego
    • Rex Bionics Ltd.
    • Caltech
    • Ossur
    • Steeper Inc
    • Boston Scientific Corporation
    • Medtronic Plc
    • Ottobock
    • RGK Wheelchair

第8章 附录

简介目录

The North American quadriplegia care devices market is poised for substantial growth, driven by the increasing prevalence of spinal cord injuries and ongoing technological advancements. Projected by Fairfield Market Research, the market is expected to reach $506.86 million by 2024, growing to $741 million by 2031, reflecting a steady compound annual growth rate (CAGR) of 5.6%. This growth is fueled by robust demand for hospital beds and specialized medical equipment tailored to enhance mobility, comfort, and overall quality of life for quadriplegic patients.

Market Dynamics The market's growth trajectory is supported by the increasing number of spinal cord injury cases reported annually in North America. According to data from the National Spinal Cord Injury Statistical Center, thousands of new spinal cord injury cases are recorded each year, necessitating advanced medical solutions such as robotic arm systems, prosthetics, and other assistive devices. These innovations cater to the unique needs of quadriplegic patients, fostering a more inclusive and supportive healthcare environment.

Sales Analysis and Market Outlook Over the past five years, the North American market for quadriplegia care devices expanded at a steady pace, reflecting the growing demand for specialized care. The sales analysis from 2016 to 2020 highlights a consistent increase in the adoption of these devices, driven by factors such as the rising prevalence of spinal cord injuries and advancements in medical technology. Looking ahead, the market is expected to continue its upward trajectory, with a focus on delivering cutting-edge solutions that improve patient outcomes.

Technological Advancements Driving Market Growth Technological innovations are at the heart of the market's growth, with recent developments in computer science, robotics, artificial intelligence, and sensor technology broadening the range of applications for quadriplegia care devices. Powered wheelchairs, for example, have revolutionized mobility for quadriplegic patients by incorporating control and navigational intelligence. These advanced devices are designed to enhance efficiency, reduce stress, and offer greater flexibility, thereby improving the overall quality of life for users.

Product Innovations and Market Opportunities The market is witnessing a surge in product innovations aimed at addressing the specific needs of quadriplegic patients. For instance, the introduction of new orthopaedic braces with hot and cold therapy features has significantly improved patient comfort and treatment outcomes. These dual-feature braces are set to dominate the market, replacing conventional systems and driving future growth.

Key Opportunities for Manufacturers The increasing prevalence of spinal cord injuries and the rapid pace of technological advancements present significant opportunities for quadriplegia care device manufacturers. The widespread acceptance and adoption of these advanced devices, driven by rigorous research and early product launches, are creating a fertile ground for market expansion. Additionally, the efforts of non-governmental organizations (NGOs) to raise awareness about conditions such as osteoporosis are expected to further boost the demand for quadriplegia care solutions.

Challenges and Restraints Despite the promising growth prospects, the market faces several challenges. High costs associated with advanced braces and the regulatory hurdles imposed by agencies such as the FDA are significant barriers to market entry for new players. Additionally, the availability of second-hand quadriplegia care devices, often donated or resold, poses a challenge to the growth of new product sales. However, these challenges also present opportunities for manufacturers to innovate and develop cost-effective solutions that comply with regulatory standards.

Country-wise Insights The U.S. dominates the North American quadriplegia care devices market, driven by a high incidence of quadriplegia and a strong healthcare infrastructure. The country's market share is bolstered by the consolidation among healthcare providers and the widespread adoption of advanced devices to reduce healthcare costs. Meanwhile, Canada, with a notable incidence of spinal cord injuries, represents a growing market for quadriplegia care devices. The increasing number of spinal cord injury cases in Canada is expected to drive demand for advanced treatment solutions.

Product and Indication Analysis Hospital beds are among the most in-demand quadriplegia care products, accounting for a significant market share. These technologically-advanced beds, designed specifically for paraplegic and quadriplegic care, provide enhanced comfort and improved health outcomes. In terms of indications, sports injuries and car accidents are the most common causes of incomplete quadriplegia, driving the demand for specialized care devices.

Competitive Analysis

  • ReWalk Robotics
  • Ekso Bionics
  • Indego (Parker Hannifin Corporation)
  • Rex Bionics Ltd.
  • Caltech
  • Ossur
  • Steeper, Inc.
  • Boston Scientific corporation
  • Medtronic Plc.
  • Ottobock
  • RGK Wheelchairs
  • Rifton Equipment
  • Allard USA, Inc.
  • Fillauer LLC
  • College Park Industries
  • Mobius Bionics.
  • Parker Hannifin
  • Nevro
  • ProBed Medical Technologies Inc.
  • BLUE CHIP MEDICAL
  • Restorative Therapies
  • MYOLYN, LLC

Key Segments in North America Quadriplegia Care Devices Industry Survey

North America Quadriplegia Care Devices Market by Product:

  • Stimulation Devices
    • Spinal Cord Stimulators
    • Functional Electrical Stimulation (FES) Systems
  • Assistive Devices
    • Exoskeletons
    • Robotic Arm Systems
    • Prosthetics

§ Upper Limb Prosthetics

§ Lower Limb Prosthetics

  • Mobility Devices
    • Wheelchairs
    • Crutches & Walkers
    • Gait Trainers
  • Hospital Beds
  • Transfer Bench and Boards
  • Braces & Supports
  • Orthopaedic Splints
  • Others Supportive Devices

North America Quadriplegia Care Devices Market by Indication:

  • Incomplete Quadriplegia
  • Complete Quadriplegia

North America Quadriplegia Care Devices Market by End User:

  • Rehabilitation Centres
  • Assistive Living Facilities
  • Long-term Care Centers
  • Home Care Settings

North America Quadriplegia Care Devices Market by Country:

  • U.S Quadriplegia Care Devices Market
  • Canada Quadriplegia Care Devices Market

Table of Contents

1. Executive Summary

  • 1.1. North America Quadriplegia Care Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Emerging Technologies for Support & Care
  • 2.4. Regulatory Scenario
  • 2.5. Value Chain Analysis
  • 2.6. Porter's Five Forces Analysis
  • 2.7. COVID-19 Impact Analysis
    • 2.7.1. Supply
    • 2.7.2. Demand
  • 2.8. Economic Overview
    • 2.8.1. World Economic Projections
  • 2.9. PESTLE Analysis

3. Price Analysis, 2018 - 2024

  • 3.1. North America Average Price Analysis, by Product, US$ Per Unit, 2018 - 2024
  • 3.2. Prominent Factor Affecting Quadriplegia Care Devices Prices
  • 3.3. North America Average Price Analysis, by Region, US$ Per Unit

4. North America Quadriplegia Care Devices Market Outlook, 2018 - 2031

  • 4.1. North America Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Stimulation Devices
      • 4.1.1.2. Assistive Devices
      • 4.1.1.3. Mobility Devices
      • 4.1.1.4. Hospital Beds
      • 4.1.1.5. Transfer Bench and Boards
      • 4.1.1.6. Braces & Supports
      • 4.1.1.7. Orthopaedic Splints
      • 4.1.1.8. Others Supportive Devices
  • 4.2. North America Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Incomplete Quadriplegia
      • 4.2.1.2. Complete Quadriplegia
  • 4.3. North America Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Rehabilitation Centres
      • 4.3.1.2. Assistive Living Facilities
      • 4.3.1.3. Long-term Care Centres
      • 4.3.1.4. Home Care Settings
  • 4.4. North America Quadriplegia Care Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S.
      • 4.4.1.2. Canada

5. U.S. Quadriplegia Care Devices Market Outlook, 2018 - 2031

  • 5.1. U.S. Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Stimulation Devices
      • 5.1.1.2. Assistive Devices
      • 5.1.1.3. Mobility Devices
      • 5.1.1.4. Hospital Beds
      • 5.1.1.5. Transfer Bench and Boards
      • 5.1.1.6. Braces & Supports
      • 5.1.1.7. Orthopaedic Splints
      • 5.1.1.8. Others Supportive Devices
  • 5.2. U.S. Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Incomplete Quadriplegia
      • 5.2.1.2. Complete Quadriplegia
  • 5.3. U.S. Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Rehabilitation Centres
      • 5.3.1.2. Assistive Living Facilities
      • 5.3.1.3. Long-term Care Centres
      • 5.3.1.4. Home Care Settings
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Canada Quadriplegia Care Devices Market Outlook, 2018 - 2031

  • 6.1. Canada Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Stimulation Devices
      • 6.1.1.2. Assistive Devices
      • 6.1.1.3. Mobility Devices
      • 6.1.1.4. Hospital Beds
      • 6.1.1.5. Transfer Bench and Boards
      • 6.1.1.6. Braces & Supports
      • 6.1.1.7. Orthopaedic Splints
      • 6.1.1.8. Others Supportive Devices
  • 6.2. Canada Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Incomplete Quadriplegia
      • 6.2.1.2. Complete Quadriplegia
  • 6.3. Canada Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Rehabilitation Centres
      • 6.3.1.2. Assistive Living Facilities
      • 6.3.1.3. Long-term Care Centres
      • 6.3.1.4. Home Care Settings
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Competitive Landscape

  • 7.1. Company Market Share Analysis, 2024
  • 7.2. Competitive Dashboard
  • 7.3. Company Profiles
    • 7.3.1. ReWalk Robotics
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Product Portfolio
      • 7.3.1.3. Financial Overview
      • 7.3.1.4. Business Strategies and Development
    • 7.3.2. Ekso Bionics
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Product Portfolio
      • 7.3.2.3. Financial Overview
      • 7.3.2.4. Business Strategies and Development
    • 7.3.3. Indego (Parker Hannifin Corporation)
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Product Portfolio
      • 7.3.3.3. Financial Overview
      • 7.3.3.4. Business Strategies and Development
    • 7.3.4. Rex Bionics Ltd.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Product Portfolio
      • 7.3.4.3. Financial Overview
      • 7.3.4.4. Business Strategies and Development
    • 7.3.5. Caltech
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Product Portfolio
      • 7.3.5.3. Financial Overview
      • 7.3.5.4. Business Strategies and Development
    • 7.3.6. Ossur
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Product Portfolio
      • 7.3.6.3. Financial Overview
      • 7.3.6.4. Business Strategies and Development
    • 7.3.7. Steeper Inc
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Product Portfolio
      • 7.3.7.3. Financial Overview
      • 7.3.7.4. Business Strategies and Development
    • 7.3.8. Boston Scientific Corporation
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Product Portfolio
      • 7.3.8.3. Financial Overview
      • 7.3.8.4. Business Strategies and Development
    • 7.3.9. Medtronic Plc
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Product Portfolio
      • 7.3.9.3. Financial Overview
      • 7.3.9.4. Business Strategies and Development
    • 7.3.10. Ottobock
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Product Portfolio
      • 7.3.10.3. Financial Overview
      • 7.3.10.4. Business Strategies and Development
    • 7.3.11. RGK Wheelchair
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Product Portfolio
      • 7.3.11.3. Financial Overview
      • 7.3.11.4. Business Strategies and Development

8. Appendix

  • 8.1. Research Methodology
  • 8.2. Report Assumptions
  • 8.3. Acronyms and Abbreviations